Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility
about
Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genesSusceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGSFunctional characterization of infiltrating T lymphocytes in human hepatic allografts.Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitopeSpecific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis.Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.Molecular localization of human class II MT2 and MT3 determinantsStructural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules.HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.Clusters of HLA class II beta restriction fragments describe allelic series.Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications.Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells.Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.
P2860
Q24605083-69CACAB0-D8B8-4C79-974C-CD941AA3CB88Q34287477-2AEFF174-770D-4103-BD64-8520AE49A08AQ34396506-B2EDBDEC-23D1-4113-BAEB-97D87CEADE66Q34420983-891B3490-D891-4A14-91A4-0BBDEB17C51BQ34558392-EAA89CB2-B84A-49DE-BC69-3F9723D6B1A3Q34612436-71CB3FFD-B69A-4D65-8255-4E4782EBEA3BQ36230935-45413560-4EB3-47D7-BEE1-B5981F022D15Q36349420-9B8E91D4-1A7E-45FA-A0E1-30D42ABFE801Q36350713-AED10A91-8A45-4171-ABDA-61534D00B70DQ36353471-66A45BF5-68EB-4018-9A32-87567A15486EQ37512053-B3D9A27F-0E99-45D3-9917-ED0BE4CD77C5Q37580530-218AA5EB-6138-4F6B-883F-DA93A1A628A4Q37680789-2A2D3E62-4B3B-4F03-BE4E-221CD1B17D17Q37688753-3E4DB42D-CAED-4A32-A3B3-640FADD653A6Q39729253-13036FB1-79B1-4D1A-BBCC-66706C67057CQ41824608-08F580AB-D45A-4122-8102-512C8841B3CBQ42936920-DFBFCAC6-759C-4908-AD90-7D09F068DA99Q42937041-907C2582-71BD-4A9D-8267-33AB1CEF2BF8Q42937207-C3F513F9-AEB9-475C-850B-1D60665CF363
P2860
Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility
description
1983 nî lūn-bûn
@nan
1983 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Further characterization of HL ...... ons and disease susceptibility
@ast
Further characterization of HL ...... ons and disease susceptibility
@en
Further characterization of HL ...... ons and disease susceptibility
@nl
type
label
Further characterization of HL ...... ons and disease susceptibility
@ast
Further characterization of HL ...... ons and disease susceptibility
@en
Further characterization of HL ...... ons and disease susceptibility
@nl
prefLabel
Further characterization of HL ...... ons and disease susceptibility
@ast
Further characterization of HL ...... ons and disease susceptibility
@en
Further characterization of HL ...... ons and disease susceptibility
@nl
P2860
P356
P1476
Further characterization of HL ...... ons and disease susceptibility
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.18.5719
P407
P577
1983-09-01T00:00:00Z